Investigational drug · Phase 2
HSK42360-Na
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Metastatic Colorectal Cancer (CRC).
Phase 2Last checked: Nov 20, 2026Latest source record: Aug 27, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "HSK42360-Na"
First trial start
2026
Aug 12, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "HSK42360-Na", any sponsor or status.
Conditions studied
As listed on its trial records.
- Metastatic Colorectal Cancer (CRC)
Approved drugs for the same conditions: Colorectal cancer · Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "HSK42360-Na" as an intervention, largest first.
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT07790510 · 180 participants (planned) · Start Aug 12, 2026 · Primary completion Sep 30, 2029
Drug: HSK42360-Na Tablets; Cetuximab (EGFR inhibitor) and 2 more · For: Metastatic Colorectal Cancer (CRC)
Sites: Beijing, China
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT07561554 · 159 participants (planned) · Start Mar 6, 2026 · Primary completion Dec 2, 2028
Drug: HSK42360-Na · For: Solid Tumors (Phase 1)
Sites: Beijing, China · 2 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Metastatic Colorectal Cancer (CRC)
- RilogrotugPhase 31 trial
AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome
- SSGJ-706Phase 23 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · Non Small Cell Lung Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC)
- NelmastobartPhase 22 trials
STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer
- DES-1357Phase 21 trial
D. E. Shaw Research, LLC · Metastatic Colorectal Cancer (CRC)
- ETX-929Phase 21 trial
Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.